Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov 11;6(1):394.
doi: 10.1038/s41392-021-00814-x.

A pan-cancer fingerprint: common molecular denominators of the human tumor microenvironment

Susanna S Ng #  1 , Sonia Leonardelli #  1 , Michael Hölzel  2
Affiliations
Comment

A pan-cancer fingerprint: common molecular denominators of the human tumor microenvironment

Susanna S Ng et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Four distinct pan-cancer tumor microenvironment (TME) subtypes. The schematic summarizes the features of the TME that define the immune-enriched, fibrotic (IE/F), immune-enriched, non-fibrotic (IE), fibrotic (F), and desert/immune-depleted (D) subtypes. These subtypes can predict immunotherapy response and survival outcome. The integration of subtype-defining gene expression signatures with data of genomic alterations generates a global visualization of tumors, termed the Molecular Functional (MF) portrait. TMB, tumor mutational burden. Figure generated on Biorender.com
See this image and copyright information in PMC

Comment on

References

    1. Bagaev A, et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell. 2021;39:845–865.e7. doi: 10.1016/j.ccell.2021.04.014. - DOI - PubMed
    1. Donoghue MTA, Schram AM, Hyman DM, Taylor BS. Discovery through clinical sequencing in oncology. Nat. Cancer. 2020;1:774–783. doi: 10.1038/s43018-020-0100-0. - DOI - PMC - PubMed
    1. Kubli, S. P., Berger, T., Araujo, D. V., Siu, L. L. & Mak, T. W. Beyond immune checkpoint blockade: emerging immunological strategies. Nat. Rev. Drug Discov. 1–21, 10.1038/s41573-021-00155-y (2021). - PubMed
    1. Charoentong P, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18:248–262. doi: 10.1016/j.celrep.2016.12.019. - DOI - PubMed
    1. Thorsson V, et al. The immune landscape of cancer. Immunity. 2018;48:812–830.e14. doi: 10.1016/j.immuni.2018.03.023. - DOI - PMC - PubMed

Publication types

Substances